TCIM
ALIM

TIAA CREF Investment Management’s Alimera Sciences ALIM Stock Holding History

TIAA CREF Investment Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,912
Closed -$181K – 3198
2016
Q1 		$181K Hold
6,912
– – ﹤0.01% 2996
2015
Q4 		$251K Hold
6,912
– – ﹤0.01% 3043
2015
Q3 		$229K Hold
6,912
– – ﹤0.01% 3024
2015
Q2 		$478K Buy
6,912
+530
+8% +$36.6K ﹤0.01% 2970
2015
Q1 		$480K Hold
6,382
– – ﹤0.01% 2930
2014
Q4 		$530K Sell
6,382
-337
-5% -$27.4K ﹤0.01% 2942
2014
Q3 		$546K Sell
6,719
-639
-9% -$54.6K ﹤0.01% 2939
2014
Q2 		$660K Buy
7,358
+1,887
+34% +$168K ﹤0.01% 2936
2014
Q1 		$647K Buy
5,471
+927
+20% +$90K ﹤0.01% 2864
2013
Q4 		$321K Sell
4,544
-389
-8% -$15.9K ﹤0.01% 3048
2013
Q3 		$278K Sell
4,933
-1,097
-18% -$68.8K ﹤0.01% 3032
2013
Q2 		$441K Buy
+6,030
New +$348K ﹤0.01% 2965

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TIAA CREF Investment Management's ALIM Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of Alimera Sciences (ALIM) in Q2 2016, closing a stake of 6,912 shares — an estimated $181K sold.

TIAA CREF Investment Management first reported a position in ALIM in Q2 2013 and held it in 12 quarters. The position peaked at $660K in Q2 2014. 49 funds tracked by Wall St. Rank hold ALIM as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining Alimera Sciences position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 6,912 Alimera Sciences shares in Q2 2016, an estimated $181K.
  • TIAA CREF Investment Management first reported a position in Alimera Sciences in Q2 2013 and held it in 12 quarters.
  • TIAA CREF Investment Management's Alimera Sciences position peaked at $660K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.